The present study characterized natural killer cells and cytokines in diabetic mothers, their placenta, and fetus. In the maternal blood from the hyperglycemic groups, the CD16+CD56−NK cells increased, whereas that of CD16+CD56+decreased in gestational diabetes mellitus [GDM] group. Cord blood from type 2 diabetes [DM-2] showed a higher proportion of CD16+CD56−and CD16−CD56+. The placental extravillous layer of GDM and DM-2 showed an increase of CD16+CD56−cells and, irrespective of region, the proportion of CD16−CD56+cells was higher in mild gestational hyperglycemia [MGH] and GDM and lower in DM-2. IL-2 was lower in maternal blood and IFN-γhigher in maternal and cord blood from the GDM group. IL-17 was higher in maternal and cord blood from the DM-2 group. The placental extravillous layer of the MGH showed high levels of IL-4, IL-6, IL-10, IL-17, and IFN-γand low levels of IL-1βand IL-8, whereas the placental villous layer contained high levels of IL-17 and IFN-γ. The GDM group, irrespective of region, showed higher levels of IL-8. The DM-2 group, irrespective of region, placenta showed high levels of TNF-α, IL-17, and IFN-γ. The hyperglycemia produces an inflammatory environment with a high content of inflammatory cytokines and cells expressing CD16+.
Melatonin is involved in a number of physiological and oxidative processes, including functional regulation in human milk. The present study investigated the mechanisms of action of melatonin and its effects on the functional activity of colostral phagocytes in diabetic women. Colostrum samples were collected from normoglycemic (N = 38) and diabetic (N = 38) women. We determined melatonin concentration, superoxide release, bactericidal activity and intracellular Ca2+ release by colostral phagocytes treated or not with 8-(Diethylamino) octyl-3,4,5-trimethoxybenzoate hydrochloride (TMB-8) and incubated with melatonin and its precursor (N-acetyl-serotonin-NAS), antagonist (luzindole) and agonist (chloromelatonin-CMLT). Melatonin concentration was higher in colostrum samples from hyperglycemic than normoglycemic mothers. Melatonin stimulated superoxide release by colostral phagocytes from normoglycemic but not hyperglycemic women. NAS increased superoxide, irrespective of glycemic status, whereas CMTL increased superoxide only in cells from the normoglycemic group. Phagocytic activity in colostrum increased significantly in the presence of melatonin, NAS and CMLT, irrespective of glycemic status. The bactericidal activity of colostral phagocytes against enterophatogenic Escherichia coli (EPEC) increased in the presence of melatonin or NAS in the normoglycemic group, but not in the hyperglycemic group. Luzindole blocked melatonin action on colostrum phagocytes. Phagocytes from the normoglycemic group treated with melatonin exhibited an increase in intracellular Ca2+ release. Phagocytes treated with TMB-8 (intracellular Ca2+ inhibitor) decreased superoxide, bactericidal activity and intracellular Ca2+ release in both groups. The results obtained suggest an interactive effect of glucose metabolism and melatonin on colostral phagocytes. In colostral phagocytes from normoglycemic mothers, melatonin likely increases the ability of colostrum to protect against EPEC and other infections. In diabetic mothers, because maternal hyperglycemia modifies the functional activity of colostrum phagocytes, melatonin effects are likely limited to anti-inflammatory processes, with low superoxide release and bactericidal activity.
7 April 2015 in The Journal of Maternal-Fetal & Neonatal Medicine
Objective: The present study evaluated the cells and cytokine of maternal blood, cord blood and colostrum of diabetic mothers. Methods: The women evaluated were divided according to their body mass index (BMI) and glycemic status into non-diabetic (ND – N = 15), mild gestational hyperglycemic (MGH – N = 15), diabetes mellitus gestational (DMG – N = 13) and type-2 diabetes mellitus (DM2 – N = 15) groups. The subsets of cells and cytokine profile were determined by flow cytometry. Results: Maternal blood from MGH group had increase percentage of CD3+T cells, and DM-2 group had decrease percentage of CD4+ T cells. The cord blood from hyperglycemic groups showed lower percentage of CD3+ T cells expressing CD45RO+ and higher of CD4+ T cells and CD4+ T cells expressing CD45RA+. In the colostrum, the CD4+ T cells and CD4+ T cells expressed CD45RA+ increase in hyperglycemic groups. The DM2 group exhibited higher IL17 levels in maternal blood. IFN-γ was lower in cord blood from MGH and DMG groups with overweight/obese. Irrespective of the glycemic status, IL6 was higher in colostrum. Conclusion: The results obtained suggest that maternal hyperglycemia modifies the phenotypes of T cells and cytokines profile in maternal, cord blood and colostrum.
Circadian rhythms affect the circulating levels of proteins that can modulate immune responses. Cytokines represent a group of proteins present in breast milk that modulate the immune system, but the effects of fluctuations of these proteins have not yet been elucidated. In this work, the cytokines present in human milk were quantified, taking into account the phases of the day and the maturation stages of human milk. Samples were collected at different stages of milk maturation and in two phases, day and night. The levels of cytokines IL-2, IL-4, IL-6, IL-10, TNF-α, INF-γ and IL-17 were evaluated by flow cytometry. All quantified cytokines showed chronobiological variations with regard to the phase of day and/or stage of breast milk maturation. These data indicate that cytokines are subjected to fluctuations, and this knowledge is important for the use of human breast milk as an intervention strategy.
17 December 2013 in Journal of Immunology Research
Immune response changes induced by diabetes are a risk factor for infections during pregnancy and may modify the development of the newborn’s immune system. The present study analyzed colostrum and maternal and cord blood of diabetic women to determine (1) the levels of the cytokines IFN-γand TGF-βand (2) phagocytic activity after incubation with cytokines.Methods.Colostrum and maternal and cord blood samples were classified into normoglycemic (N= 20) and diabetic (N= 19) groups. Cytokine levels, superoxide release, rate of phagocytosis, bactericidal activity, and intracellular Ca2+release by phagocytes were analyzed in the samples. Irrespective of glycemic status, IFN-γand TGF-βlevels were not changed in colostrum and maternal and cord blood. In maternal blood and colostrum, superoxide release by cytokine-stimulated phagocytes was similar between the groups. Compared to spontaneous release, superoxide release was stimulated by IFN-γand TGF-βin normoglycemic and diabetic groups. In the diabetic group, cord blood phagocytes incubated with IFN-γexhibited higher phagocytic activity in response to EPEC, and maternal blood exhibited lower microbicidal activity. These data suggest that diabetes interferes in maternal immunological parameters and that IFN-γand TGF-βmodulate the functional activity of phagocytes in the colostrum, maternal blood, and cord blood of pregnant diabetic women.